Development of risk prediction models for breast, ovarian and prostate cancer
The CanRisk (cancer risk) assessment tool is being designed to assist clinicians in all clinical settings including primary care and genetics clinics.
The CanRisk (cancer risk) assessment tool is being designed to assist clinicians in all clinical settings including primary care and genetics clinics.
This study will look at how often GPs follow the guidelines and whether certain types of patients or patients with certain symptoms are more or less likely to be urgently referred when the guidelines suggest they should be.
This PhD will be the first series of studies in Australia to test and measure the acceptability and usefulness of skin self-monitoring apps for melanoma from a patient perspective.
Our previous work found that cancer risk was greatly increased for people with clinically high platelets (cells in the blood that enable clotting). The NORMA study will investigate whether people with platelet counts at the high end of the normal range are also at increased risk of cancer.
This study is part of a wider Health and Technology Assessment study whose overall aim is to understand the effectiveness, cost-effectiveness and current use of cancer diagnostic tools to aid decision-making in primary care.
The aims of this research are to explore changes in time to cancer diagnosis and estimate the early impact of the revision of NICE guidelines for suspected cancer on the time to diagnosis of cancer.
Abdominal pain is a symptom commonly reported to United Kingdom general practitioners. This research will help guide GPs to provide appropriate action for patients with unexplained abdominal pain.
In this multi-stage project, we will use routinely collected data to map how patients with ovarian cancer are currently evaluated and investigated in UK primary care, prior to diagnosis.